0001857036-21-000001.txt : 20210429
0001857036-21-000001.hdr.sgml : 20210429
20210429122049
ACCESSION NUMBER: 0001857036-21-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20210429
DATE AS OF CHANGE: 20210429
EFFECTIVENESS DATE: 20210429
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Boston Biopharma, Inc.
CENTRAL INDEX KEY: 0001857036
IRS NUMBER: 901028064
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-397638
FILM NUMBER: 21868687
BUSINESS ADDRESS:
STREET 1: 570 COLONIAL PARK DRIVE, SUITE 309
CITY: ROSWELL
STATE: GA
ZIP: 30075
BUSINESS PHONE: 5082190200
MAIL ADDRESS:
STREET 1: 570 COLONIAL PARK DRIVE, SUITE 309
CITY: ROSWELL
STATE: GA
ZIP: 30075
D
1
primary_doc.xml
X0708
D
LIVE
0001857036
Boston Biopharma, Inc.
570 COLONIAL PARK DRIVE, SUITE 309
ROSWELL
GA
GEORGIA
30075
5082190200
DELAWARE
Boston Biopharmaceuticals, Inc.
None
Corporation
true
Ahmad
Hashem
14065 Crabapple Lake Drive
Roswell
GA
GEORGIA
30076
Executive Officer
Director
Director and Chief Executive Officer
Peter
Gerhard
Wodtke
81 Green Hill Road
Washington
CT
CONNECTICUT
06793-1494
Director
Chairman of the Board of Directors
Terry
Kevin
Clark
465 South Timberwood Circle
Palmer
AK
ALASKA
99645
Director
Director and Chief Medical Officer
Ammar
Hemaidan
994 Waterford Pointe Dr.,
Port Orange
FL
FLORIDA
32127
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2020-03-11
true
true
false
0
Indefinite
1515000
Indefinite
false
15
0
0
N/A
0
The gross proceeds of the offering have not been used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above.
false
Boston Biopharma, Inc.
/Ahmad Hashem/
Ahmad Hashem
Director, CEO
2021-04-29